Access to doctors by drug sales reps are down 13 percent, according to a new report. That translates to about $2 billion a year in expenses and salaries lost to pharmaceutical giants supporting the 90,000 reps who make up the U.S. sales force. Six percent of doctors reportedly will not see reps from any company.